Pfizer Inc. (NYSE: PFE) and its partner BioNTech SE (NASDAQ: BNTX) announced the completion of the Phase 3 clinical trial of their
Pfizer concludes COVID-19 vaccine trial with efficacy of 95%; will apply for EUA within days
Pfizer Inc. (NYSE: PFE) and its partner BioNTech SE (NASDAQ: BNTX) announced the completion of the Phase 3 clinical trial of their
Palatin Technologies, Inc. (AMEX: PTN) Q1 2021 earnings call dated Nov. 17, 2020 Corporate Participants: Carl Spana -- President and Chief Executive Officer Stephen
Pfizer Inc. (NYSE: PFE) and Moderna Inc. (NASDAQ: MRNA) have made significant progress in their efforts to develop a vaccine against the
The market has been closely following the activities of leading biopharma companies for some time, looking for updates on their COVID vaccine
Shares of Moderna Inc. (NASDAQ: MRNA) were up over 8% in morning trade on Monday as the company reported positive results from
Bio-Path Holdings, Inc. (NASDAQ: BPTH) Q3 2020 earnings call dated Nov. 13, 2020 Corporate Participants: Will O'Connor -- Stern Investor Relations Peter Nielsen -- President, Chief
Biocept Inc (NASDAQ: BIOC) Q3 2020 earnings call dated Nov. 12, 2020 Corporate Participants: Bruce Voss -- Investor Relations Michael W. Nall -- President and Chief
Shares of Beyond Air Inc. (NASDAQ: XAIR) gained over 3% in midday trade on Thursday. The stock has climbed 5% since the
PDL BioPharma, Inc. (NASDAQ: PDLI) Q3 2020 earnings call dated Nov. 11, 2020 Corporate Participants: Jody Cain -- Senior Vice President, LHA Dominique Monnet -- President
Beyond Air, Inc. (NASDAQ: XAIR) Q2 2021 earnings call dated Nov. 11, 2020 Corporate Participants: Maria Yonkoski -- Head of Investor Relations Steve Lisi -- Chief
The controversy surrounding biotechnology firm Biogen's (NASDAQ: BIIB) Alzheimer's drug Aducanumab took a positive turn last week after the FDA issued a
10x Genomics, Inc. (NASDAQ: TXG) Q3 2020 earnings call dated Nov. 10, 2020 Corporate Participants: Eric Jaschke -- Director of Investor Relations and Strategic
Affimed N.V. (NASDAQ: AFMD) Q3 2020 earnings call dated Nov. 10, 2020 Corporate Participants: Alexander Fudukidis -- Head of Investor Relations Adi Hoess -- Chief Executive
Aurora Cannabis Inc. (NYSE: ACB) Q1 2021 earnings call dated Nov. 09, 2020 Corporate Participants: Miguel Martin -- Chief Executive Officer Glen Ibbott -- Chief Financial
Shares of Pfizer Inc. (NYSE: PFE) rallied on Monday after the company reported positive results from its Phase 3 trial for its
Immunogen Inc (NASDAQ: IMGN) Q3 2020 earnings call dated Nov. 06, 2020 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications and Investor
CVS Health Corp. (NYSE: CVS) Q3 2020 earnings call dated Nov. 06, 2020 Corporate Participants: Valerie C Haertel -- Senior Vice President, Investor Relations
Ampio Pharmaceuticals Inc (NYSE American: AMPE) Q3 2020 Earnings Call dated Nov. 05, 2020 Corporate participants: Joseph Hassett -- Investor Relations Michael Macaluso -- Founder, Chairman
Cigna Corp (NYSE: CI) Q3 2020 earnings call dated Nov. 05, 2020 Corporate Participants: Alexis Jones -- Lead Principal, Investor Relations David Cordani -- President and
Amarin Corporation plc (NASDAQ: AMRN) Q3 2020 earnings call dated Nov. 05, 2020 Corporate Participants: Elisabeth Schwartz -- Senior Director, Investor Relations John Thero -- President
Cardinal Health Inc. (NYSE: CAH) Q1 2021 earnings call dated Nov. 05, 2020 Corporate Participants: Kevin Moran -- Vice President, Investor Relations Mike Kaufmann -- Chief